Skip to main content

Table 2 Number of cats with positive faecal egg counts and, for the fluralaner-moxidectin group, comparison of pre- and post-treatment faecal egg counts, per protocol population

From: A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus)

Group

Nematode species

Number positive

Difference post- vs pre-treatmentb

Probability

Pre-treatment

Post-treatment

Mean

SE

Fluralaner / moxidectin

Toxocara cati

142

3 (97.89%)

5.8920

0.1130

t (141) = 52.13;

P < 0.0001

Toxascaris leonina

15

0 (100%)

4.8470

0.2520

t(14) = 19.24;

P < 0.0001

Capillaria spp.

14

0 (100%)

4.8449

0.1996

t(13) = 24.28;

P < 0.0001

Hookworm spp.a

55

0 (100%)

5.5334

0.1534

t(54) = 36.07;

P < 0.0001

Emodepside / praziquantel

Toxocara cati

73

2 (97.26%)

 

Toxascaris leonina

6

0 (100%)

Capillaria spp.

4

0 (100%)

Hookworm spp.a

22

0 (100%)

  1. aHookworm spp. include Anyclostoma tubaeforme and Uncinaria stenocephala
  2. bDifferences not calculated for emodepside/praziquantel
  3. Abbreviation: SE, standard error